Clinical trials
No Condition clinical trials
Below are recruiting no condition clinical trials, each written for real people, not researchers. We’re tracking 720 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07590635Recruiting
Heart Recovery Program Using Online Health Tools
This study tests a new heart rehabilitation program that combines online tools with personalized support for people who've had heart procedures. It aims to help you recover safely and manage your heart health from home.
BergenAges 18 years+ - NCT07588438RecruitingPhase 4
Tirzepatide effectiveness and safety for diabetes and weight loss in Paraguay
This study tests how well and safely tirzepatide (a new injectable medication) works in real-world conditions for people with type 2 diabetes or obesity in Paraguay. The medication helps lower blood sugar and reduce weight.
AsunciónAges 18–70 - NCT07586735Recruiting
A new preparative regimen for stem cell transplant in older patients with severe aplastic anemia
This study tests a new combination of drugs to prepare older patients (40–60 years old) with severe aplastic anemia for a stem cell transplant from a half-matched donor. The goal is to make the transplant safer and more effective for this age group.
Beijing, Beijing MunicipalityAges 40–60 - NCT07578441Enrolling by invitation
VitaSmart HOPE System liver transplant registry
This study follows people who receive a liver transplant using a special machine called the VitaSmart HOPE System, which keeps the donated liver healthy before transplant. The study tracks how well these livers work after transplant.
Cleveland, OhioAges Any age - NCT07583888RecruitingPhase 2/Phase 3
VABu Conditioning for Older Adults with Acute Myeloid Leukemia
This trial tests a chemotherapy regimen (VABu) combined with a stem-cell transplant for older adults (60+) with acute myeloid leukemia (a blood cancer) who previously responded well to Venetoclax-based treatment. The goal is to see if this approach improves outcomes after transplant.
Suzhou, JiangsuAges 60 years+ - NCT07581704RecruitingPhase 1
Sirolimus plus immunotherapy for relapsed multiple myeloma
This study tests whether a drug called sirolimus, given before certain immunotherapy treatments (teclistamab or talquetamab), helps these treatments work better against multiple myeloma. These immunotherapies teach your immune cells to attack myeloma cells.
Iowa City, IowaAges 18 years+ - NCT07582172RecruitingPhase 2
Stem Cell Transplant for Hard-to-Treat Blood Cancers in Older Adults
This trial tests a new combination of radiation and chemotherapy to prepare your body for a stem cell transplant from a matched donor. It's designed for older patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) that hasn't responded well to standard treatments.
Duarte, CaliforniaAges 18 years+ - NCT06724627Recruiting
AI skin check app for walk-in clinic patients
This trial tests a smartphone-based AI system that helps diagnose skin conditions. It may offer faster, more accurate diagnosis for people visiting a walk-in clinic with a skin problem.
The Bronx, New YorkAges Any age - NCT06029049RecruitingPhase 4
Comparing two muscle relaxants for faster breathing tube placement
This study tests two different muscle relaxant drugs—rocuronium and succinylcholine—to see which one helps doctors place a breathing tube faster during emergency anesthesia. It may be a good fit for people who need general anesthesia for surgery and have either a high body mass index or a difficult airway.
Houston, TexasAges 18 years+ - NCT07576933Enrolling by invitation
Exercise Programs for People With Intellectual Disabilities
This study tests two different exercise programs to see which one better improves fitness and quality of life for people with intellectual disabilities. You'll participate in structured physical activity sessions over several weeks.
Murcia, MurciaAges 19–37 - NCT07565220RecruitingPhase 1
Thiotepa-based stem cell transplant for blood cancers
This trial tests a new chemotherapy preparation (using thiotepa) before a stem cell transplant from a matched donor to treat blood cancers like leukemia and myelodysplastic syndrome. The goal is to improve survival while reducing severe side effects.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT07556380Recruiting
Mobile app to help melanoma survivors stay safe in the sun
This study helps people who've had melanoma learn healthy habits around sun exposure and outdoor activity. You'll use a smartphone app, wear special tracking devices, and share information about your time outside to help researchers develop better ways to protect skin cancer survivors.
Chicago, IllinoisAges 18 years+ - NCT05477589RecruitingPhase 3
Conditioning plan for kids with AML before stem cell transplant
This Phase 3 trial studies the best “conditioning” chemotherapy plan before an allogeneic stem cell transplant for children with AML. It may help improve outcomes by testing an approach for kids who are ready for transplant after relapse or specific high-risk features.
BrusselsAges Up to 18 years - NCT07548125Recruiting
Exercise to help process trauma memories
This study tests whether exercise before therapy helps people with PTSD reduce their trauma-related fear and anxiety. You'll do aerobic exercise, then work with a therapist on trauma memories while your brain activity is measured in an MRI machine.
Austin, TexasAges 18–55 - NCT07550075Recruiting
Support program for Korean American dementia caregivers
This study tests a virtual support program designed specifically for Korean American adults who care for family members with dementia. The program aims to help caregivers manage stress and learn practical caregiving skills through online classes.
Los Angeles, CaliforniaAges 18 years+ - NCT07548983RecruitingPhase 1
Maintenance therapy after stem cell transplant for AML
This trial tests whether taking two drugs, ruxolitinib and azacitidine, after a reduced-intensity stem cell transplant can help prevent acute myeloid leukemia (AML) from returning. It is for patients who are in remission and at high risk of relapse.
Portland, OregonAges 18 years+ - NCT07536399RecruitingPhase 3
Bone Marrow Treatment for Jaw Joint Pain Relief
This study tests whether injecting your own bone marrow cells into your jaw joint during a minimally invasive procedure can reduce pain and improve jaw function better than arthroscopy alone. It's for people with significant jaw pain that hasn't improved with conservative treatments like NSAIDs, physical therapy, and bite splints.
New York, New YorkAges 18–75 - NCT07539519Recruiting
Mental Health Treatment Toolkit for Autistic Teens
This study tests a new toolkit designed to help therapists better treat mental health conditions in autistic teenagers. Researchers want to improve care by training therapists to understand autism and how it affects mental health treatment.
Miami, FloridaAges 13 years+ - NCT07539662Enrolling by invitation
Cord Blood Stem Cell Transplant for ALS
This trial tests whether a transplant of special cells from donated umbilical cord blood can help slow or improve symptoms of ALS (amyotrophic lateral sclerosis, also called Lou Gehrig's disease). The cells may help repair nerve damage and reduce disease progression.
TianjinAges 35–50 - NCT07534436Recruiting
Eye Surgery Outcomes and Mental Health in Congenital Ptosis
This study follows patients before and after surgery for congenital ptosis—a condition where the eyelid droops from birth. Researchers will measure how surgery affects vision and emotional well-being.
Guangzhou, GuangdongAges 3–60 - NCT06756152RecruitingPhase 2/Phase 3
Preventing GVHD after transplant for blood cancers in children and young adults
This trial tests a combination of four medicines (cyclophosphamide, abatacept, vedolizumab, and ruxolitinib) to prevent graft-versus-host disease (GVHD) after a stem cell transplant for children and young adults with certain blood cancers. The goal is to see if this approach reduces the risk of GVHD, a serious complication where donor cells attack the body.
MoscowAges 1 day–21 years - NCT07531914Recruiting
Testing a Brain Function Assessment for ADHD and Autism
This study validates a new computer-based test that measures how well your brain can focus and control impulses. Researchers want to see if it works reliably for people with ADHD or autism.
UmeåAges 18 years+ - NCT06302010Recruiting
Stress ball for anxiety during high-risk pregnancy test
This study tests whether squeezing a stress ball during a non-stress test (baby heartbeat check) can help lower anxiety and improve well-being for women with high-risk pregnancies. It's for women who are at least 32 weeks pregnant.
SamsunAges 18–45 - NCT07520929Recruiting
How Sauna Sessions Affect Blood Sugar Control
This study tests whether spending time in a sauna can help your body control blood sugar levels. You'll visit a lab twice to try a sauna session and have your blood sugar measured, which could help researchers understand if heat therapy benefits people with weight or metabolism concerns.
Charlottetown, Prince Edward IslandAges 30–55
Hear when a new No Condition trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for no condition?
- Yes. Clin2 currently lists 720 recruiting no condition studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a no condition trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a no condition trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.